202 related articles for article (PubMed ID: 18670643)
1. Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.
Wang J; Yu W; Cai Y; Ren C; Ittmann MM
Neoplasia; 2008 Aug; 10(8):847-56. PubMed ID: 18670643
[TBL] [Abstract][Full Text] [Related]
2. FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.
Yu W; Feng S; Dakhova O; Creighton CJ; Cai Y; Wang J; Li R; Frolov A; Ayala G; Ittmann M
Clin Cancer Res; 2011 Jul; 17(13):4355-66. PubMed ID: 21622724
[TBL] [Abstract][Full Text] [Related]
3. Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression.
Feng S; Shao L; Yu W; Gavine P; Ittmann M
Clin Cancer Res; 2012 Jul; 18(14):3880-8. PubMed ID: 22573348
[TBL] [Abstract][Full Text] [Related]
4. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.
Wang J; Stockton DW; Ittmann M
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6169-78. PubMed ID: 15448004
[TBL] [Abstract][Full Text] [Related]
5. Association between fibroblast growth factor receptor-4 gene polymorphism and risk of prostate cancer: a meta-analysis.
Liwei L; Chunyu L; Jie L; Ruifa H
Urol Int; 2011; 87(2):159-64. PubMed ID: 21625079
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
[TBL] [Abstract][Full Text] [Related]
7. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
Giri D; Ropiquet F; Ittmann M
Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of the metastasis-associated gene Ehm2 in prostate cancer.
Wang J; Cai Y; Penland R; Chauhan S; Miesfeld RL; Ittmann M
Prostate; 2006 Nov; 66(15):1641-52. PubMed ID: 16927306
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing of fibroblast growth factor receptors in human prostate cancer.
Kwabi-Addo B; Ropiquet F; Giri D; Ittmann M
Prostate; 2001 Feb; 46(2):163-72. PubMed ID: 11170144
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K
Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
12. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M
BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172
[TBL] [Abstract][Full Text] [Related]
13. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
Freeman KW; Gangula RD; Welm BE; Ozen M; Foster BA; Rosen JM; Ittmann M; Greenberg NM; Spencer DM
Cancer Res; 2003 Oct; 63(19):6237-43. PubMed ID: 14559809
[TBL] [Abstract][Full Text] [Related]
14. Role of fibroblast growth factor receptor 4 in cancer.
Tang S; Hao Y; Yuan Y; Liu R; Chen Q
Cancer Sci; 2018 Oct; 109(10):3024-3031. PubMed ID: 30070748
[TBL] [Abstract][Full Text] [Related]
15. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
[TBL] [Abstract][Full Text] [Related]
16. FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.
Ho CK; Anwar S; Nanda J; Habib FK
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):94-6. PubMed ID: 19918264
[TBL] [Abstract][Full Text] [Related]
17. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
Feng S; Shao L; Castro P; Coleman I; Nelson PS; Smith PD; Davies BR; Ittmann M
Oncotarget; 2017 Jan; 8(4):6179-6192. PubMed ID: 28008155
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
[TBL] [Abstract][Full Text] [Related]
20. Role of fibroblast growth factor receptor signaling in prostate cancer cell survival.
Ozen M; Giri D; Ropiquet F; Mansukhani A; Ittmann M
J Natl Cancer Inst; 2001 Dec; 93(23):1783-90. PubMed ID: 11734594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]